Form 8-K - Current report:
SEC Accession No. 0001193805-15-001047
Filing Date
2015-06-25
Accepted
2015-06-25 17:19:43
Documents
3
Period of Report
2015-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e613839_8k-adma.htm 8-K 53501
2 e613839_ex99-1.htm EX-99.1 15536
3 GRAPHIC adma.jpg GRAPHIC 7298
  Complete submission text file 0001193805-15-001047.txt   80826
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 15952501
SIC: 2836 Biological Products, (No Diagnostic Substances)